Aseko, Inc.
GREENVILLE, SC · Founded 2008 · CIK 0001369701 · Medtech · Private
Membrane probe sensors and reagent-based systems for automated pool water quality monitoring and disinfection control
aseko.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $63M
- 18 Form D · Nov 2022
- 46 months since last filing
- Contracts
- $191K
- 1 award · Veterans Affairs
- #460 of 4531 in medtech
- Patents
- 40
- 35 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20082010201220142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $131,415 | |
| Private capital raised | Form D · SEC | $100,000 | |
| Private capital raised | Form D · SEC | $462,150 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $8,273,078 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $2,525,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $1,475,000 | |
| Private capital raised | Form D · SEC | $3,499,997 | |
| Private capital raised | Form D · SEC | $2,971,815 | |
| Private capital raised | Form D · SEC | $2,500,000 | |
| Private capital raised | Form D · SEC | $2,500,000 | |
| Private capital raised | Form D · SEC | $4,999,865 | |
| Private capital raised | Form D · SEC | $4,062,500 | |
| Private capital raised | Form D · SEC | $4,703,605 | |
| Private capital raised | Form D · SEC | $1,375,000 | |
| Private capital raised | Form D · SEC | $6,411,522 | |
| Federal contract | Department of Veterans Affairs · Glucose Monitoring Software. | $191,090 | |
| Private capital raised | Form D · SEC | $5,999,999 | |
| Private capital raised | Form D · SEC | $9,252,750 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 457 | NANOMATERIAL INNOVATION LTD | $200K | — |
| 458 | Ambergen, Inc. | $200K | $5.0M |
| 459 | KINETIC RIVER CORP. | $195K | — |
| 460 | Aseko, Inc. | $191K | $63M |
| 461 | REDLEN TECHNOLOGIES INC | $191K | $2.7M |
| 462 | ORTHALIGN INC | $185K | $46M |
| 463 | LEDA HEALTH CORPORATION | $184K | $9.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John BenekeExecutive Officer
- Bruce BodeDirector
- Robby BoothExecutive Officer
- Robert BoothExecutive Officer
- Donald CaseyDirector
- Patrick CuaDirector
- Deborah DeanDirector
- Joseph DiverExecutive Officer
- Robert FischellDirector · Executive Officer
- Scott FischellDirector
- Tim FischellDirector
- Jay FleischmanDirector
- Eddie FloydDirector
- Edward FloydDirector
- Daniel FrankDirector · Executive Officer
- Danny FrankDirector
- Paul FulchinoDirector
- Edmond FurlongDirector · Executive Officer
- Scott GottliebDirector
- Sue GradyExecutive Officer
- Randall HawkinsExecutive Officer
- Randy HawkinsExecutive Officer
- Greg HowardExecutive Officer
- Gregory HowardExecutive Officer
- Robert LeonardDirector · Executive Officer
- Bill MatthewsExecutive Officer
- William MatthewsExecutive Officer
- Raymie McFarlandExecutive Officer
- Andrew MidlerDirector · Executive Officer
- Molly O'NeillDirector
- Cheryl PegusDirector
- Megan PietropaoloExecutive Officer
- Robert RosenDirector
- Charlie SmithDirector
- Lionel SterlingDirector
- Trefor ThomasDirector · Executive Officer
- Phil TorrenceExecutive Officer
- Phillip TorrenceExecutive Officer
- Lynn VogelDirector
- Stephen WallackExecutive Officer
Patents
- A Method And Dosing Controller For Adminstering A Correction Dose Of Insulingranted
- A Method And System For Insulin Managementgranted
- Advising Diabetes Medicationsgranted
- Insulin Managementgranted
- Diabetes Management Therapy Advisorgranted
- Subcutaneous Outpatient Managementgranted
- Insulin Managementgranted
- Advising Diabetes Treatmentsgranted
- Advising Diabetes Medicationsgranted
- Managing Insulin Administrationapplication
- Insulin Managementgranted
- System And Method For Optimizing Insulin Dosages For Diabetic Subjectsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.